Comment on Galvez-Fernandez et al. Urinary Zinc and Incident Type 2 Diabetes: Prospective Evidence From the Strong Heart Study. Diabetes Care 2022;45:2561–2569

We read with great interest the article by Galvez-Fernandez et al. (1) about the association of urinary zinc (UZn) (single exposure) with the risk of type 2 diabetes mellitus (T2DM) among 1,339 adults in the Strong Heart Study (SHS) and 1,905 family members of SHS participants in the Strong Heart Family Study (SHFS). The authors reported that higher UZn levels were statistically significantly associated with increased T2DM risk in the SHS cohort but not in the SHFS cohort. In the sensitivity analyses, the authors evaluated the association of UZn with T2DM risk by adjusting for urinary arsenic (UAs) and selenium (USe) levels using the conventional regression models. However, this study did not report details on the interactions with important predictors, levels of metal concentrations and their correlations, and explanations for their possible influence, although the combined effects of UZn, UAs, and USe on T2DM were not their primary focus.

Bekijk het originele bericht

Wellicht vindt u dit ook interessant

Meld u aan voor de maandelijkse nieuwsbrief

Patiëntvoorbeelden m.b.t. vergoeding

Voeg je koptekst hier toe

Vergoeding diabetesmiddelen

Apothekersinstructies:

Er zijn 2 soorten terugbetalingsregelingen:
* TBR: patiënt declareert online of per post of de apotheker declareert namens de patiënt online
** HEVO-Consult: patiënt betaalt kosten eerst zelf en stuurt declaratie naar HEVO-Consult